Epoch Investment Partners Inc. decreased its position in Chemed Corporation (NYSE:CHE – Free Report) by 22.4% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 250,123 shares of the company’s stock after selling 72,285 shares during the period. Epoch Investment Partners Inc.’s holdings in Chemed were worth $94,481,000 as of its most recent filing with the SEC.
A number of other large investors have also recently bought and sold shares of CHE. Northwestern Mutual Wealth Management Co. grew its stake in shares of Chemed by 2,444,879.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares in the last quarter. Norges Bank bought a new stake in shares of Chemed in the fourth quarter worth $76,067,000. AQR Capital Management LLC lifted its position in shares of Chemed by 89.2% in the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after purchasing an additional 153,469 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Chemed by 1,260.2% during the fourth quarter. Victory Capital Management Inc. now owns 117,685 shares of the company’s stock worth $50,353,000 after purchasing an additional 109,033 shares during the last quarter. Finally, M&T Bank Corp boosted its holdings in Chemed by 10,291.1% during the fourth quarter. M&T Bank Corp now owns 85,934 shares of the company’s stock worth $36,768,000 after purchasing an additional 85,107 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.
Insiders Place Their Bets
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director owned 4,578 shares in the company, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 3.33% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Analysis on Chemed
Chemed Stock Up 1.4%
Chemed stock opened at $510.28 on Friday. The company’s 50-day moving average price is $458.59 and its two-hundred day moving average price is $433.65. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. The stock has a market cap of $6.77 billion, a P/E ratio of 27.81, a P/E/G ratio of 1.85 and a beta of 0.52. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $517.74.
Chemed (NYSE:CHE – Get Free Report) last issued its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The company had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business’s revenue was up 1.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.63 earnings per share. As a group, analysts expect that Chemed Corporation will post 22.67 EPS for the current year.
Chemed Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is currently 13.08%.
About Chemed
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Featured Articles
- Five stocks we like better than Chemed
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
